Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology

• Published in: Pharmacological research 2020-06, Vol.156, p.104793-104793, Article 104793
• Main Authors: Jozefczuk, E., Guzik, T.J., Siedlinski, M.
• Format: Article
• Language: English
• Subjects: Animals; Cardiovascular diseases; Cardiovascular Diseases - metabolism; Cardiovascular Diseases - pathology; Cardiovascular Diseases - physiopathology; Cardiovascular System - embryology; Cardiovascular System - metabolism; Cardiovascular System - physiopathology; Embryonic Development; Heart; Hemodynamics; Humans; Immune system; Lysophospholipids - metabolism; Neovascularization, Physiologic; Receptors, Lysosphingolipid - metabolism; Signal Transduction; Sphingosine - analogs & derivatives; Sphingosine - metabolism; Sphingosine kinase; sphingosine-1-phosphate; Vasculature
• ISSN: 1043-6618; 1096-1186
• DOI: 10.1016/j.phrs.2020.104793

[Display omitted] Sphingosine-1-phosphate (S1P) is a signaling lipid, synthetized by sphingosine kinases (SPHK1 and SPHK2), that affects cardiovascular function in various ways. S1P signaling is complex, particularly since its molecular action is reliant on the differential expression of its receptors (S1PR1, S1PR2, S1PR3, S1PR4, S1PR5) within various tissues. Significance of this sphingolipid is manifested early in vertebrate development as certain defects in S1P signaling result in embryonic lethality due to defective vasculo- or cardiogenesis. Similar in the mature organism, S1P orchestrates both physiological and pathological processes occurring in the heart and vasculature of higher eukaryotes. S1P regulates cell fate, vascular tone, endothelial function and integrity as well as lymphocyte trafficking, thus disbalance in its production and signaling has been linked with development of such pathologies as arterial hypertension, atherosclerosis, endothelial dysfunction and aberrant angiogenesis. Number of signaling mechanisms are critical – from endothelial nitric oxide synthase through STAT3, MAPK and Akt pathways to HDL particles involved in redox and inflammatory balance. Moreover, S1P controls both acute cardiac responses (cardiac inotropy and chronotropy), as well as chronic processes (such as apoptosis and hypertrophy), hence numerous studies demonstrate significance of S1P in the pathogenesis of hypertrophic/fibrotic heart disease, myocardial infarction and heart failure. This review presents current knowledge concerning the role of S1P in the cardiovascular system, as well as potential therapeutic approaches to target S1P signaling in cardiovascular diseases.